Insulet Corp (PODD)
170.42
-1.45
(-0.84%)
USD |
NASDAQ |
May 01, 16:00
167.89
-2.53
(-1.48%)
After-Hours: 20:00
Insulet Accounts Receivable (Quarterly): 359.70M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 359.70M |
September 30, 2023 | 270.30M |
June 30, 2023 | 250.50M |
March 31, 2023 | 217.20M |
December 31, 2022 | 205.60M |
September 30, 2022 | 201.40M |
June 30, 2022 | 206.60M |
March 31, 2022 | 189.30M |
December 31, 2021 | 161.00M |
September 30, 2021 | 114.30M |
June 30, 2021 | 100.30M |
March 31, 2021 | 97.90M |
December 31, 2020 | 95.30M |
September 30, 2020 | 85.40M |
June 30, 2020 | 78.00M |
March 31, 2020 | 80.10M |
December 31, 2019 | 69.30M |
September 30, 2019 | 65.05M |
June 30, 2019 | 66.96M |
March 31, 2019 | 68.66M |
December 31, 2018 | 63.30M |
September 30, 2018 | 69.95M |
June 30, 2018 | 49.68M |
March 31, 2018 | 50.38M |
December 31, 2017 | 53.37M |
Date | Value |
---|---|
September 30, 2017 | 47.17M |
June 30, 2017 | 37.75M |
March 31, 2017 | 40.65M |
December 31, 2016 | 28.80M |
September 30, 2016 | 38.55M |
June 30, 2016 | 38.70M |
March 31, 2016 | 40.47M |
December 31, 2015 | 42.53M |
September 30, 2015 | 31.80M |
June 30, 2015 | 31.83M |
March 31, 2015 | 36.09M |
December 31, 2014 | 39.88M |
September 30, 2014 | 47.14M |
June 30, 2014 | 41.80M |
March 31, 2014 | 36.68M |
December 31, 2013 | 33.07M |
September 30, 2013 | 34.46M |
June 30, 2013 | 33.65M |
March 31, 2013 | 31.11M |
December 31, 2012 | 33.29M |
September 30, 2012 | 30.14M |
June 30, 2012 | 25.59M |
March 31, 2012 | 26.20M |
December 31, 2011 | 23.19M |
September 30, 2011 | 17.27M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
65.05M
Minimum
Sep 2019
359.70M
Maximum
Dec 2023
153.38M
Average
114.30M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
Abbott Laboratories | 6.565B |
Stryker Corp | 3.765B |
Becton Dickinson & Co | 2.267B |
Haemonetics Corp | 211.61M |
Tandem Diabetes Care Inc | 105.56M |